Buy ATYR by Aug 1, 2025.

There’s nothing I like to see more than ill-informed shorts taking a position against a stock when the odds are heavily skewed in my favor. When ACHR started to move higher in October of 2024, short interest was as high as 28%, which created a nearly 300% short squeeze. In biotech, those swings could be even more violent with ATYR as at least 15 million shares are now in the Russell Indexes, which is essentially decreasing float (available shares) while …